Named patient imports to New Zealand offer hope to patients amidst present hurdles with access to modern medicines for serious ailments. This case study highlights the benefits of the program.
Named patient supply of unlicensed medicines to the UK can help tackle medicine access challenges for costly treatments not covered by the NHS. Here is a case study on these solutions.
In Brazil, access to costly cancer & rare disease drugs is a challenge. In this case study, we analyze possible solutions, such as named patient supply to Brazil.